文献速递主动脉疾病

术中放置Palmaz支架治疗EVAR后Ia型内漏的长期耐久性

The Long-term Durability of Intra-operatively Placed Palmaz Stents for the Treatment of Type Ia Endoleaks After EVAR of Abdominal Aortic Aneurysm.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2016-11-25

这项回顾性队列研究分析了125例腹主动脉瘤EVAR术中放置Palmaz支架处理Ia型内漏患者的长期耐久性及瘤颈形态演变。中位随访43个月,5年无Ia型内漏率原发性84±4%、辅助性89±3%,择期患者更优;但择期患者5年 crude 成功率优于急性患者,相对成功率无差异。结论认为Palmaz支架提供高长期无内漏率,可作为急性期补救工具,但不应在择期EVAR中用于扩展至更困难解剖。

要点

  • 术中Palmaz支架治疗Ia型内漏5年无内漏率原发性84±4%、辅助性89±3%。
  • 择期患者5年crude成功率优于急性患者,但相对成功率无差异。
  • Palmaz支架可作为急性期补救工具,不应用于择期扩展至困难解剖。

核心结论

  • 术中放置Palmaz支架提供高长期无Ia型内漏率,可作为急性期补救工具,但不应在择期EVAR中用于扩展至更困难解剖。

研究设计与样本

  • 回顾性队列研究,在三级转诊中心进行,纳入1998至2012年治疗的125例患者(择期83例、破裂22例、症状性20例)。

主要发现

  • 中位随访43个月(范围15-72),围手术期死亡9例(择期2例、急性7例),晚期AAA相关死亡7例,再干预51例(其中Ia型内漏相关7例)。
  • 5年crude原发性、辅助原发性和二次成功率分别为55±5%、66±5%和70±5%,择期患者更优(p=.008、p=.031、p=.037),但相对成功率无差异(p=.187、p=.640、p=.558)。
  • 术后5年无Ia型内漏的原发性和辅助性分别为84±4%和89±3%,择期患者更优(p=.066和p=.145),相对率分析更优(p=.025和p=.063)。
  • 首次与末次术后影像间,内脏主动脉直径显著增加的患者比例在腹腔干、肠系膜上动脉、最低肾动脉和最低肾动脉远端9 mm处分别为15/91(16%)、12/91(13%)、34/91(37%)和30/91(33%)。

关键数值与推荐

  • 5年crude原发性、辅助原发性和二次成功率分别为55±5%、66±5%和70±5%。
  • 5年无Ia型内漏的原发性和辅助性分别为84±4%和89±3%。
  • 择期患者crude成功率更优(p=.008、p=.031、p=.037),相对成功率无差异(p=.187、p=.640、p=.558)。
  • 择期患者无Ia型内漏率更优(p=.066和p=.145),相对率分析更优(p=.025和p=.063)。

临床怎么用

  • 术中Palmaz支架可用于急性期Ia型内漏的补救治疗。
  • 择期EVAR中不应使用Palmaz支架将适应症扩展至更困难解剖。
  • 术后需长期影像随访监测内漏及内脏主动脉直径变化。

局限性

  • 回顾性队列研究,单中心三级转诊中心经验。
  • 随访时间范围15-72个月,部分患者随访可能不完整。
  • 择期与急性患者基线特征可能影响crude成功率比较。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE/BACKGROUND: The objective was to analyze the long-term durability of intra-operatively placed Palmaz stents for type Ia endoleaks, and the evolution of aneurysm neck morphology. METHODS: This was a retrospective cohort study conducted at a tertiary referral centre. Patients treated between 1998 and 2012 were reviewed with regard to pre-, intra-, and post-operative data. Crude and relative survival estimates were calculated, with the latter referring only to patients with ≥ 3 months' follow-up. RESULTS: In total, 125 patients were included (83 elective, 22 ruptures, 20 symptomatic). Nine patients died perioperatively (two elective, seven acute). Median follow-up was 43 months (range 15-72). Seven patients had late abdominal aortic aneurysm related deaths. There were 51 re-interventions (seven type Ia endoleak related). Five year crude primary, primary assisted, and secondary success rates were 55 ± 5%, 66 ± 5%, and 70 ± 5%, respectively. These crude rates were superior for elective patients (p = .008, p = .031, and p = .037, respectively), but the relative rates were not (p = .187, p = .640, p = .558, respectively). Primary and assisted freedom from type Ia endoleak 5 years post-operatively were 84 ± 4% and 89 ± 3%, respectively. These rates were superior in elective patients (p = .066 and p = .145, respectively), especially when relative rates were analysed (p = .025 and p = .063, respectively). The visceral aortic diameter increased significantly between the first and the last post-operative imaging in 15/91 (16%), 12/91 (13%), 34/91 (37%), and 30/91 (33%) patients at the levels of coeliac trunk, superior mesenteric artery, lowest renal artery, and 9 mm distal to lowest renal artery, respectively. CONCLUSION: Intra-operatively placed Palmaz stents confer high long-term freedom from type Ia endoleak. Palmaz stents are an acceptable intra-operative bailout tool in the acute setting, but should not be used to extend elective infrarenal endovascular aneurysm repair to more demanding anatomies.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Abdulrasak M, Resch T, Sonesson B, et al. The Long-term Durability of Intra-operatively Placed Palmaz Stents for the Treatment of Type Ia Endoleaks After EVAR of Abdominal Aortic Aneurysm. Eur J Vasc Endovasc Surg. 2016. PMID: 27894897. doi:10.1016/j.ejvs.2016.10.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。